In silico analysis predicts interaction between Na-K-ATPase (NKA) and Bcl-2 protein canonical BH3-and BH1-like motifs, consistent with NKA inhibition by the benzo-phenanthridine alkaloid chelerythrine, a BH3 mimetic, in fetal human lens epithelial cells (FHLCs) (Lauf PK, Heiny J, Meller J, Lepera MA, Koikov L, Alter GM, Brown TL, Adragna NC. Cell Physiol Biochem 31: [257][258][259][260][261][262][263][264][265][266][267][268][269][270][271][272][273][274][275][276] 2013). This report establishes proof of concept: coimmunoprecipitation and immunocolocalization showed unequivocal and direct physical interaction between NKA and Bcl-2 proteins. Specifically, NKA antibodies (ABs) coimmunoprecipitated BclXL (B-cell lymphoma extra large) and BAK (Bcl-2 antagonist killer) proteins in FHLCs and A549 lung cancer cells. In contrast, both anti-Bcl-2 ABs failed to pull down NKA. Notably, the molecular mass of BAK1 proteins pulled down by NKA and BclXL ABs appeared to be some 4-kDa larger than found in input monomers. In silico analysis predicts these higher molecular mass BAK1 proteins as alternative splicing variants, encoding 42 amino acid (aa) larger proteins than the known 211-aa long canonical BAK1 protein. These BAK1 variants may constitute a pool separate from that forming mitochondrial pores by specifically interacting with NKA and BclXL proteins. We propose a NKA-Bcl-2 protein ternary complex supporting our hypothesis for a special sensor role of NKA in Bcl-2 protein control of cell survival and apoptosis. Na-K-ATPase; Bcl-2 proteins BclXL and Bak; immunochemistry; human lens epithelial cells; cancer cells PROTEINS OF THE BCL-2 (B-cell lymphoma 2) family are crucial cytosolic and membrane-bound players in cell survival (29) and programmed death or apoptosis (36). The ratios of the prosurvival proteins Bcl-2, BclXL, and Mlc-1 to the proapoptotic proteins BAK, BAX, and BAD (7, 41) (see term identification below) appear to be critical in these processes. The two antagonistic protein groups possess up to four canonical motifs (BH1-4) and heterodimerize through their BH1-like grooves and BH3 motifs, respectively, to prevent BAK and BAX homodimerization and their mitochondrial pore formation that initiates cell death (31). Since apoptosis has been long known to be associated with K ϩ loss and Na ϩ gain (1), i.e., an inversion of the normal K ϩ /Na ϩ ratio maintained by Na-KATPase (NKA), potential links between NKA and apoptosis have been postulated (25), without exactly identifying cellular partners in this process.
PROTEINS OF THE BCL-2 (B-cell lymphoma 2) family are crucial cytosolic and membrane-bound players in cell survival (29) and programmed death or apoptosis (36) . The ratios of the prosurvival proteins Bcl-2, BclXL, and Mlc-1 to the proapoptotic proteins BAK, BAX, and BAD (7, 41 ) (see term identification below) appear to be critical in these processes. The two antagonistic protein groups possess up to four canonical motifs (BH1-4) and heterodimerize through their BH1-like grooves and BH3 motifs, respectively, to prevent BAK and BAX homodimerization and their mitochondrial pore formation that initiates cell death (31) . Since apoptosis has been long known to be associated with K ϩ loss and Na ϩ gain (1), i.e., an inversion of the normal K ϩ /Na ϩ ratio maintained by Na-KATPase (NKA), potential links between NKA and apoptosis have been postulated (25) , without exactly identifying cellular partners in this process.
For quite some time, NKA has been associated with cellular metabolism and ion transport: for instance, binding of digitalis to the NKA receptor (39) and inhibition of NKA by oligomycin and vanadate (14) activate signaling cascades via closely associated Src (sarcoma) (39) and phospatidylinositol 3-kinase (PI3K) proteins (38) , effects that have also been linked to changes in the ATP/ADP ratio (34) . Recently, it was shown that gastrointestinal infection-elicited Shiga toxin 2-induced apoptosis is attenuated by ouabain-mediated decrease in the BAX/BclXL ratio (4) . After the discovery of the K-Cl cotransporters (KCC) (20) , a functional complex of the KCC3a isoform with the NKA ␣1-subunit in lipid rafts of gastric parietal cells was shown (13) in which NKA was inhibited by the relative unspecific KCC inhibitor [(dihydroindenyl)oxy] acetic acid (DIOA) (12) . However, as obvious as it would seem, a direct physical interaction between NKA and Bcl-2 proteins controlling the fate of the cell, although suspected (33), has not yet been established, according to our knowledge.
Previously, we used in silico analysis to map putative Bcl-2 protein-canonical motifs in human NKA ␣1-subunits. These putative motifs share sequence homologies with both BH1-groove-and BH3-like regions present in the prosurvival BclXL (B-cell lymphoma extra-large) and Bcl-2 as well as in the proapoptotic BAK (Bcl-2-antagonist/killer) and BAX (Bcl-2-associated X) proteins, respectively (21) . This prediction was based on the finding that chelerythrine (CHE), a quaternary benzene phenanthridine alkaloid (5, 11) , a known PKC inhibitor (16) , and BH3-mimetic binder to BclXL proteins (6, 43) , inhibited NKA in fetal human lens epithelial cells (FHLCs) nearly completely at 50 M and after a 20-min exposure time (21) . It was proposed that CHE acts via an intracellular site at the BH1-like-groove on NKA and not via competition at its ouabain receptor nor by PKC-mediated phosphorylation of NKA because neither was directly affected (21) . Moreover, surface-enhanced Raman spectroscopy revealed cellular uptake of CHE by FHLCs at levels higher than predicted from Nernst distribution of the positively charged drug (10) .
As a logical extension of our previous study, the present work used immunochemical methods to provide further evidence that NKA possesses Bcl-2-type canonical motifs interacting with both prosurvival and proapoptotic Bcl-2 proteins. Our coimmunoprecipitation and immunocolocalization data reveal in FHLCs and A549 human lung carcinoma cells direct physical interaction between NKA and both BclXL and BAK proteins. In the process of confirming interactions between NKA, and BclXL and BAK, we have serendipitously identified a longer NKA-interacting isoform of BAK1 protein. In silico analysis predicts that this longer isoform may reflect an alternative splicing variant, encoding 42 amino acids (aa) larger BAK molecules than the canonical 211-aa long BAK1 (31) . These novel findings support the notion of a special sensor role of NKA proposed by us in the Bcl-2 protein control of cellular survival and apoptosis (21) by associating into a ternary complex with BclXL proteins and a pool of BAK1 variant proteins.
A preliminary account of this work was given at the 14th International Conference on P-type ATPases in Lunteren, The Netherlands, September 2014.
MATERIALS AND METHODS
Chemicals. D-Glucose (anhydrous dextrose), Tris-base [Tris-(hydroxymethyl)-amino-methane], HEPES, sodium chloride (NaCl), magnesium chloride (MgCl 2), dibasic anhydrous sodium phosphate (Na2HPO4), potassium chloride (KCl), and DMSO were obtained from Fisher Scientific (Newark, NJ). Tween 20 polysorbate was bought from VWR (Radnor, PA), monobasic potassium phosphate (KH 2PO4) from T. J. Baker (Pittsburgh, PA), and methanol from EMD Millipore Chemicals (Philadelphia, PA). Trypsin 0.05%, M199 with L-glutamine, fetal clone III, and heat-inactivated horse serum were purchased from Thermo Fischer Scientific (Waltham, MA), gentamicin from Life Technology (Carlsbad, CA), and keratinocyte growth medium from Lonza (Allendale NJ).
Antibodies. Monoclonal rabbit (rb) anti-BclXL (E18) and anti-BAK Y164 antibodies (ABs) were procured from Abcam Biotech (Cambridge, England). Mouse (ms) monoclonal anti-ATP1A2 ␣1-subunit ABs (M7-PB-E9, clone C464.6) were from Millipore (Billerica, MA), mouse anti-NKA ␣1-subunit AB (␣6F) from Iowa Hybridoma Bank (Iowa, IA), and polyclonal rb anti-human (h) BAK ABs from Santa Cruz Biotechnology (Dallas, TX). Secondary ABs, either alkaline phosphatase-conjugated affinity-purified goat (gt) anti-rb IgG FC-H chain fragment or gt anti-ms IgG L chain specific, and Cy3-and FITC-conjugated donkey (dk) anti-rb or dk anti-ms IgG, and Alexa Fluo 488-labeled dk anti-rb IgG were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). A third secondary antibody was gt anti-ms IgG from Life Technologies (Waltham, MA).
Cell cultures. FHL124 ECs (FHL124) human lens epithelial cells, a primary fetal human lens cell line with established genomic background (32, 37) , were a gift from John Reddan, Oakland University, and were extensively used previously in defining intermediate conductance K channels (22) . FHLCs cells were grown to near confluence in either T75 flasks (BioLite 75 ml, Thermo Fischer Scientific) or 100 ϫ 20 mm Petri dishes (Corning Life Sciences, Tewksbury, MA) coated with gelatin solution type B (Sigma-Aldrich, St. Louis, MO) to enhance cell adhesion. FHLCs, passages 14 to 24, were grown in medium containing 5% horse serum, 72% Hyclone medium M199, 18% keratinocyte growth medium (KGM), and 5% HyClone FetalClone III Serum, with 2 ml gentamicin in a 5% CO 2 incubator at ambient atmospheric pressure and 37°C. Human A549 lung carcinoma cell extracts, prepared similar to FHL124 cells, were a gift from Dr. Weiween Long, Department Biochemistry and Molecular Biology, Wright State University.
Protein extraction and determination. FHL124 cells were grown to confluence in six to eight 100-mm diameter Petri dishes. To collect and disrupt cells for protein extraction, the medium was aspirated and each Petri dish was washed with 4 ml balanced salt solution [BSS; containing the following (in mM): 20 HEPES-Tris, 5 KCl, 1 MgCl 2, 10 glucose, and 300 mosM] followed by two washes with 5 ml phosphate-buffered saline [PBS containing the following (in mM): 137 NaCl, 2.7 KCl, 10 Na 2HPO4, and 2 mM KH2PO4], at room temperature (RT). Cells were removed with a scraper into 2 ml of 1ϫ PBS and 20 l of proteolysis inhibitor HALT (Thermo Fischer Scientific), transferred to 2-ml Eppendorf tubes, and centrifuged at 13,500 rpm at 4°C for 10 min in a Beckman Elutriator Centrifuge (Indianapolis, IN). Supernatants were discarded and a RIPA (RadioImmunoprecipitation Assay, Teknova, CA) buffer was added to break up the pellets that were kept on ice for 40 -60 min, vortexed every 5-10 min, and subsequently sonicated with a Misonix-3000 (ColeParmer, Vernon Hills, IL) ultrasonic cell disrupter three to five times at a low setting of 6 W. The homogenized samples were centrifuged for 10 min at 13,000 rpm at 4°C, and the clear supernatants were transferred to fresh Eppendorf tubes to be frozen at Ϫ80°C until used.
A549 cells were grown to confluence and extracted in a similar fashion to the FHLCs.
Protein was measured by the Bio-Rad Protein Assay Dye Reagent concentrate (Bio-Rad, Hercules, CA) with BSA for the calibration curve in optically transparent 96-well plates and read spectrophotometrically at 595 nm, and the protein content was calculated by OriginLab software.
Coimmunoprecipitation. Fifty microliters of Dynabeads Protein G were used per recommended micrograms of AB. For ms monoclonal anti-NKA ␣6F AB (80 l/50 l beads), and rb monoclonal antihBclXL (E18; Abcam) AB, the recommended ratio per beads was 1:10, and for polyclonal rb anti-hBak AB (G23) 1-2 g per 100 -500 g of total protein. Another monoclonal rb anti-hBAK (Y164) was used for immunoprecipitation at 1/100 dilution. Antibody was diluted in 500 l elution buffer (EB; 50 M Tris pH 7.4, 150 M NaCl, and 0.5% Nonidet P40 detergent). Fifty microliters of protein-G Dynabeads (Life Technologies) were placed into several Eppendorf tubes, captured by a magnetic bar using the MagRack 6 (GE Health Life Sciences, Pittsburgh, PA), and washed with EB. Antibody was added to the washed protein-G Dynabeads and incubated by rotating endover-end at 4°C for ϳ2-4 h. Protein-G Dynabeads were captured by magnetic bar, the supernatant was aspirated, and washed twice with 500 l EB. Cell extract protein (1-2 mg) was added and incubated overnight at 4°C. The loaded protein-G Dynabeads were washed five times with cold EB and captured with the magnet, and the EB was completely removed. One hundred microliters of Laemmli sample buffer (LSB) containing 5 mM dithiothreitol were then added to the protein-G Dynabeads that were heated at 65°C for 30 min, and the solubilized proteins were removed, transferred to fresh tubes, and loaded onto the gel for Western blot.
Western blot. Twofold-concentrated LSB (950 l LSB plus 50 l 98% ␤-mercaptoethanol and 0.1 M dithiothreitol) was added to the cell lysate with a 1:1 ratio. Samples (generally 30 l) were loaded unto either the precast 4 -15% Tris·HCl Criterion gel or the 12.5% Tris·HCl Criterion gel (both from Bio-Rad Laboratories) along with the spectra multicolor broad range molecular weight standards from Thermo Fischer Scientific. The loading buffer was composed of 25 mM Tris, 192 mM glycine, and 0.1% SDS, pH 8.4. The samples were then run at RT and 150 V for 90 min when the dye front had reached the bottom of the gel. The gel was transferred onto a 0.45-m nitrocellulose membrane (Bio-Rad) overnight at a constant current of 70 mA at 4°C using 25 mM Tris, 192 mM glycine, 10% methanol, and up to 0.5% SDS as transfer buffer. The membrane was cut and washed three times with 0.1% 1ϫ PBS-Tween for 10 min each. An adequate amount of 1% I-blocking solution (Applied Biosystems, Foster City, CA) was diluted in 0.1% 1ϫ PBS-Tween and added to the blot and incubated for 90 min. The blot was then exposed overnight at 4°C on a plate shaker to the indicated primary ms monoclonal anti-ATP1A2 AB (1:500), rb monoclonal anti-BclXL [E18] AB (1:1,000), rb monoclonal anti-BAK AB (dilution 1:1,000), and rb polyclonal anti-BAK AB (1:200 to 1:500). Thereafter, the blot was washed twice with 0.1% PBS-Tween quick wash and thrice with 0.1% 1ϫ PBS-Tween, 10 min each, and incubated with the indicated one of three secondary antibodies: alkaline phosphatase-conjugated affinity-purified gt anti-rb IgG FC fragment-specific (1:5,000), alkaline phosphatase-conjugated gt anti-ms IgG Immunostaining and colocalization analysis. FHLCs were seeded into eight-well Lab-Teck Chamber Slides (NUNC) at 3.6 ϫ 10 5 cells/well, grown during 3 days in M199 medium supplemented with 72% KBM, 5% fetal clone III, 5% heat inactivated horse serum, and gentamicin. Cells were then washed with 1ϫ PBS, fixed, and permeabilized with a freshly prepared 4% paraformaldehyde solution containing 0.1% saponin for 30 min at 4°C. After two additional washes with 1ϫ PBS, cells were blocked with 3% normal dk serum in PBS for 1 h at RT, followed by separate incubation with two pairs of primary ABs: 1) rb monoclonal BclXL ABs (Abcam) at 1:100-fold dilution and 2) ms monoclonal NKA ␣1-ABs (Millipore) at 7 g/ml mixed in 3% normal dk serum and/or 3) rb polyclonal BAK AB (Santa Cruz Biotechnology) at 1:100-fold dilution and 4) ms monoclonal NKA ␣ 1-AB (Millipore) at 7 mg/ml mixed in 3% normal dk serum for overnight at 4°C. Cells were washed thrice with 1ϫ PBS before incubation with secondary ABs: Cy3-, FITC-, and Alexa fluor 488-conjugated dk anti-rb or anti-ms IgG (Jackson ImmunoResearch Laboratories) at 1:250-fold dilution for 2 h at RT in the dark. Wells were washed thrice with 1ϫ PBS and mounted with coverslips containing Vectashield with DAPI 4=,6-diamidino-2-phenylindole (DAPI) for fluorescence microscopy. Images were obtained by an Olympus Epi-Fluorescence microscope with a "run time" Spot Scope color camera. NKA was visualized by excitation at 550 nm and emission at 570 -615 nm (red fluorescence) and BcLXL and BAK by Alexa Fluor 488 by excitation at 494 and emission at 519 nm (green fluorescence). Colocalization analysis was performed with Spot imaging software, version 4.6.4.7 and, where needed, background correction with Adobe Photoshop. NKA-BcLXL interactions were observed with an Olympus FV 1000D confocal microscopy. NKA was visualized by excitation at 550 nm and emission at 570 -615 nm (red fluorescence) and BcLXL by excitation at 494 nm and emission 519 nm (green fluorescence). Colocalization was performed with Olympus fluoview software, 4.0b view version. The final versions of the figures were made from full-resolution or upscaled versions of the original images from the source output devices.
In silico analysis. GenScan (http://genes.mit.edu/GENSCAN.html) predictions, in conjunction with ORFfinder (http://www.ncbi.nlm.nih.gov/ projects/gorf/) and alignment-based analyses, were used to map potential alternative splice variants of BAK1. GenScan (2, 3) is a well-established and widely used method for the prediction of transcripts in the human genome. The overall mass of peptides corresponding to alternative splice variants was predicted by http://web.expasy.org/cgi-bin/compute_pi/.
RESULTS AND DISCUSSION
The goal of the experiments presented here was to demonstrate in FHLCs the interaction between NKA and anti-and proapoptotic Bcl-2 proteins BclXL and BAK, respectively, by coimmunoprecipitation with various ABs against both hNKA ␣1-subunit and the two hBcl-2 proteins. FHLCs were chosen because the initial in silico prediction of canonical Bcl-2 motifs in hNKA was based on the latter's inhibition by CHE, a BH3 mimetic (21) . Since a correlation between NKA activity and BclXL expression has been found in cancer cells, extracts from human A549 epithelial cancer cells were selected as an additional cell model for the coimmunoprecipitation studies only. A third cell model, B3-HLECs, was also tested yielding principally similar results. However, we did not include these data in the article since these cells 1) were SV40 virus transformed; 2) lacked one specific PKC isoform, present in the FHL124 line; and 3) were previously extracted with a different procedure. The molecular mass of NKA (1,023 aa) is ϳ110 kDa (24) and that of BclXL (NCBI Reference Sequence: NP_612815.1, 241 aa) and BAK1 (GenBank: CAG33700, 1,211 aa) proteins is about 27 and 23 kDa, respectively. Figure 1A compares the immunoprecipitates (IPs) of NKA (with primary ms monoclonal anti-NKA ␣6F AB) and BclXL (with rb monoclonal anti-hBclXL) from solubilized extracts of two human cell lines, FHLECs (FHL124) and A549 lung cancer cells with their respective two extract inputs, all against the primary monoclonal rb antihBclXL (Abcam) and visualized with a secondary gt anti-rb Fc IgG. The latter antibody only recognizes the 50-kDa IgG H chains of the rb IgG utilized here as control (indicated by an arrow under Band ID) and hence permits detection of Bcl-2 protein bands that are within the 25-kDa molecular mass range of the here invisible IgG L chains. As expected, anti-BclXL AB detected only the expected 27-kDa protein band in inputs of the two cell lines. Based on application of equal amounts of proteins to all lanes, the band intensity should increase in the NKA and BclXL AB IPs, which indeed was observed. The relative pixel increments for the pulled down BclXL proteins vs. the inputs (unity) are given in italics under their respective IPs in Fig. 1 . Whereas the entire gel had practically no contaminant cross reaction, an ϳ100-kDa protein band was clearly visible in the BclXL pull-down of FHL124 cells, which was absent in A549 cells. It is possible that this band is due to IgG-H chain dimers. The finding is also consistent with earlier reports that Bcl-2 proteins tend to homo-oligomerize in a solvent-dependent manner (17) . However, because FHL124 and A549 cells were extracted in a closely similar way, the possibility still remains that this putative oligomerization is specific for the FHL124 cell line. Since the 100-kDa protein occurred only with the BclXL extract, homo-hetero-oligomer formation between BclXL and BAK peptides cannot be excluded (30) as it has been reported that proapoptotic BAKs require BH3 motifs for their sequestration by and release from the prosurvival Mcl-1 and BclXL proteins (35) .
NKA and BclXL.
To test for reciprocal pull down, i.e., that anti-BclXL AB IPs display NKA when probed with anti-NKA AB, Fig. 1 was reblotted with anti-hNKA (Abcam) in combination with gt anti-rb Fc fragment against rb IgG, input extracts, and NKAand BclXL-IPs from FHL124 (lens) and A549 cancer (lung) cells as indicated on the top of the gel. The presence of the 110-kDa NKA ␣1-subunit was evident in the input and the NKA pull down but not in the BclXL IP in the two cell lines.
The data in Figs. 1 and 2 are consistent with our in silicoderived hypothesis that NKA possesses motifs that interact with BH3-and BH1-like motifs of the Bcl-2 protein family (21) . Although recently challenged (14) , NKA has been long believed to directly interact through SH2/3 domains with a Src (sarcoma) tyrosine kinase (28) . However, our findings are at variance with an earlier report that both anti-NKA and anti-Src protein AB reciprocally pulled down their target's molecular partner (15) and also with recent findings that NKA ABs failed to coimmunoprecipitate Src (8) . In terms of the interaction of Bcl-2 proteins with membrane transporters, it has been recently shown that BclXL and Mcl-1 interact functionally with isoforms 1 and 3 of mitochondrial voltage-dependent anion channels mediating an increased mitochondrial Ca 2ϩ uptake (18) and by direct protein-protein interaction stimulating lung cancer cell migration through reactive oxygen species formation (19) .
NKA and BAK. Figure 3 demonstrates that in both FHL124 and A549 cell extracts anti-hNKA ABs coimmunoprecipitated BAK proteins as probed with rb polyclonal anti-BAK ABs followed by gt anti-rb Fc IgG. Again, there was only staining of the IgG H chain in the rb IgG-indicated lane paralleling its occurrence in the two cell line extracts tested. Input lanes for FHL124 and A549 cell lines revealed two Santa Cruz BAK-AB-positive bands: a 23-kDa presumably BAK1 monomer and a 36-kDa protein, which, labeled BAK cross-reacting protein (CRP), was also present in the A549 cell line. Immunoblots of anti-hBAK AB IPs from FHL124 but not from A549 cells also displayed the 23-kDa monomer. However, anti-NKA and antihBAK AB IPs from both cell extracts revealed BAK-positive bands with an apparent gel shift by some 4 kDa yielding ϳ27-kDa BAK-positive proteins. Finally, both FHL124 and A549 lung cancer cell IPs possessed an additional faint BAKantibody-positive protein band of ϳ46 kDa, apparently BAK1 dimers, which was also present in the input lane.
Because of the uniqueness of the gel shift of a polyclonal BAK-AB-positive protein band, we employed in addition a monoclonal anti-hBAK1 AB from Abcam. Figure 4 , utilizing a secondary antibody against H chains only, revealed the latter at 50 kDa and shows ϳ27-kDa molecular mass duplet and triplet bands in three pull downs, anti-BAK, anti BclXL, and anti-NKA, from FHL124 and A549 cells but also the presumable ϳ23-kDa monomer in the FHL124 input prominently present in the BAK IP. In addition, the BAK IPs revealed in FHL124 and A549 lung cancer cells several BAK-positive peptides between 35 and 40 kDa and three major peptides at molecular mass of and greater than 100 kDa, all of whom are not Right: identification (ID) by arrows of major bands: 50-kDa IgG H chain, 46-kDa BAK dimer, a 36-kDa BAK-AB-cross-reacting protein (CRP) band, a 23-kDa BAK monomer in the inputs of both cell lines and the BAK pull down, and ϳ27-kDa higher molecular mass bands, presumable splice variants of BAK1, interacting with NKA. The initial content for the 2 co-IP cell extracts (FHL124 and A549) was 1 mg, and the input loading volume was 5% (50 g). Fig. 4 . Western blot using rb anti-hBAK1 (Abcam) in combination with gt anti-rb Fc fragment against rb-IgG, input extracts and hBAK-, hBclXL-and hNKA-IPs, from 2 human epithelial cell line extracts: FHl124 (lens) and A549 cancer (lung) as indicated on the top of the gel. Original of 3 similar gels with the same primary antibody Left: molecular mass standards. Right: ID by arrows of major bands of interest in this gel: 100-kDa and greater presumable BAK tetramers, 50-kDa IgG-H chains, 46-kDa BAK dimers, a 23-kDa BAK monomer and 27-kDa higher molecular weight bands, presumable splice variants of hBAK1, interacting with hNKA and hBclXL. The initial content for the 3 co-IP cell extracts from FHL124 and A549 cells was 1 mg, and the input loading volume was 5% (50 g).
identified. It is possible that the protein bands at the 100-kDa levels constitute IgG-H chain dimers and/or at these and higher molecular mass levels multimers of BAK, known to oligomerize as function of detergents in other systems (17) .
To test whether the anti-BAK AB IPs Fig. 4 also contained NKA, we reprobed in Fig. 5 the gels of Figs. 3 and 4, with two different anti-NKA ABs, ms monoclonal anti-NKA ␣6F (University of Iowa Hybridoma Bank) (Fig. 5A ) and ms anti-NKA (Abcam) (Fig. 5B) . Both gels showed strong input signals for the 110-kDa NKA ␣1-subunit (indicated under ID with an arrow). We have not invested further efforts into identifying an ϳ 43-kDa intensely stained protein band in the homo-IPs of NKA detected with both different anti-NKA ABs in Fig. 5, A and B. Only in the case of BAK IPs and in combination with the Abcam AB in Fig. 5B , a very faint 110-kDa band appeared in both FHL124 and A549 cells, but not in combination with anti-NKA ␣6F, which reacted only with the input and the homo-IP. This faint 110-kDa band, probably due to bleachthrough from the 100-kDa BAK oligomer of Fig. 4 , was not a consistent finding.
The failure of anti-BclXL and anti-BAK ABs to coimmunoprecipitate NKA (Figs. 2 and 5 ) could be due to protein concentration effects in the immunoblot. To rule this out, we designed two independent experiments performed by two of us at the same time in which the protein input was varied at constant concentrations of NKA, BclXL and BAK ABs. In Fig.  6A, top, FHL124 inputs (lane 2), increasing protein (lanes   3-9) , and IgG (lane 10) were probed against Santa Cruz anti-BclXL ABs, and in Fig. 6A , bottom, against anti-NKA ␣1 subunit (6␣F) AB. As expected with increasing protein during the pull down, BclXL-staining intensity increased. In contrast, anti-NKA only reacted with the NKA in the input and in the NKA pull down (Fig. 6A, bottom, lanes 2 and 3) but failed to provide any signal with increasing protein (lanes 4 -9) . In Fig.  6B , top, FHL124 inputs (lane 2), increasing protein (lanes 3-9), and IgG (lane 10) were probed against Santa Cruz anti-BAK ABs, and in Fig. 6B , bottom, against anti-NKA ␣1-subunit (6␣F) AB. Again, BAK staining intensity increased with increasing protein. Note also the previously described gel shift to a higher molecular mass in the NKA and BAK IPs. Again, anti-NKA only reacted with NKA in the input and in the NKA pull down (Fig. 6B, bottom, lanes 1 and 2) but not with increasing BAK IP protein (lanes 3-9) . These data show beyond doubt that the two anti-Bcl-2 protein ABs were incapable of reciprocally coimmunoprecipitating NKA.
Staining with rb polyclonal anti-BAK AB revealed a more complex Western blot pattern of both input and IP lanes than seen with anti-BclXL antibodies. First, while a BAK1 monomer of the HLECs input lanes exhibited a molecular mass predicted by ExPASy pI/Mw tool from its 211-aa sequence as 23,409 Da, the IPs in both cell lines revealed the presence of ϳ27-kDa BAK-AB-positive protein(s) (Figs. 3, 4 , and 6B). Since these larger BAK-positive proteins were practically absent in the input of the FHLECs and A549 (Fig. 4) , they must have been enriched in the IPs by interaction with NKA and with BclXL proteins. The latter defines this newly identified peptide as a BAK1 protein variant, presumably engaging through its BH3 sites the complementary BH1 grooves on BclXL as a heterodimer (35) .
In humans, the BAK1 gene has 7,748 bases and the BAK1 protein is encoded by 6 or 7 exons on chromosome 6, occurring in 3 known spliced variants BAK1-002, -202, and -201 (http:// useast.ensembl.org). The BAK1 protein has nine ␣-helices, with ␣2 to ␣5 containing the BH3-and BH1-interactive motifs, while ␣9 constitutes the transmembrane domain. The first two isoforms have the same length of 211 aa, whereas the third isoform has only 153 aa. Although a few single nucleotide polymorphisms are known in a variety of diseases such as autoimmune diseases, aortic aneurysm, cervical, colorectal, and gastric cancers (http://atlasgeneticsoncology.org), no larger or smaller splice variants have been reported, with the exception of a neuron-specific BAK1-BH3-motif-only variant called N-BAK (27) . N-BAK transcripts are only expressed in neurons and contain a short extra exon "N" inserted between exons 4 and 5, which encodes 24 COOH-terminal aa before the transcription of the protein is terminated by a premature stop codon. Expression of N-BAK prevents apoptosis in neurons but stimulates apoptosis in nonneuronal cells (27) .
In Figs. 3, 4 , and 6, the BAK-positive protein of 27 kDa is some 4-kDa larger than the known BAK1 monomer. In silico analysis (see MATERIALS AND METHODS) of the BAK1 gene indicates possible alternative splice variants that would be consistent with the observed mass and would likely remain BAK positive by minimizing perturbation to the structure. In this context, GenScan predicts a splice variant that we consider most likely to be pulled down by NKA (and BclXL). Compared with the canonical isoform (based on the Ensembl transcript BAK1-002), for which translation starts within exon 2, the predicted variant has an alternative translation start site within exon 1. Exon 2 of the canonical transcript is skipped in the predicted new isoform, while the open reading frame continues with exon 3. As shown in Fig. 7 , bottom, the amino acid sequence of this alternative splicing consists of 253 residues, with the first 65 residues being unique and the remaining 188 COOH-terminal residues (starting at EEQVAQ that marks the beginning of exon 3) being identical to that of the canonical form (see Fig. 7 ). The entire sequence is predicted to have a mass of 28,024 Da. BAK1 is known to have at least three different splice variants, with some of the exons skipped/inserted to create different protein products (www.ensembl.org). In this context, other possibilities for alternative splicing should be considered as well. One such possibility can be traced by mapping alternative donor/acceptor sites upstream from the "ac" site of exon-4. This variant, due to an alternative intron 3-4 splicing, would insert 129 bp between exons 3 and 4 and produce an ϳ27-kDa BAK1 protein.
We would like to comment that the alternative variant that skips exon 2, while replacing the canonical NH 2 terminus with an alternative aa sequence translated from the 5=-UTR of the canonical variant, would preserve most of the structure of the standard BAK1, including functionally relevant BH motifs. Thus the putative expanded BAK1 would be expected to interact with the NKA in a manner proposed by us earlier for standard BAK1 (21) . Nevertheless, it remains to be seen what functional advantage the proposed extra sequence provides in the NKA-BAK1 interaction. Thus the predicted splice variant would be commensurate with the gel shift observed from 23 to ϳ27 kDa (Figs. 3, 4 , and 6B). Pending further molecular confirmation by cloning and mass spectroscopy, we propose as an explanation for the gel shift of BAK that both NKA and BclXL associate with a specific splice variant of BAK1, not with any of the 3 known spliced variants mentioned above, but with a 42-aa longer version which itself may display some microheterogeneity as seen in Figs. 3, 4 , and 6B. Whereas BAK1 fulfills a role in mitochondrial pore formation (23) , its proposed larger version of our study appears to be part of a NKPA/BclXL-BAK sensor complex, a hypothesis amenable to testing. An additional noteworthy observation in Fig. 3 was that A549 cancer cell extracts lacked the BAK1 monomer, but instead showed a 46-kDa dimer, which was present in the input as well as in the pull downs but absent in the FHL124 line excluding a selective interaction with NKA and BclXL. As shown in Fig. 4 , this result was repeated in the A549 cells using a monoclonal anti-BAK antibody (Abcam). Because the dimer was also present in nontransformed FHL124 cells and their NKA IP, this finding weakens the argument of a tumor-specific gel pattern. BAK dimerization has been reported as result of oxidation to an S-S bridged dimer into a proapoptotic mode (31) . Similarly, phosphorylation of BAD causes homodimerization, a process that would effectively compete with mitochondrial pore formation by BAD oligomers (23) and thus constitute an antiapoptotic protective mechanism for tumor cells. The presence in all cell line inputs of a BAK-positive 36-kDa peptide, but its absence in the IPs, suggests a protein that does not interact with NKA and BclXL. Indeed, use of a monoclonal anti-BAK AB from Abcam failed to repeat this result so that at present we assume the Santa-Cruz-derived Fig. 6 , top and bottom, EEQѧ) and thus the canonical isoform (based on the Ensembl transcript BAK1-002, top part of diagram), for which translation starts within exon 2, the known variant. As indicated at the bottom, the amino acid sequence of this alternative splicing consists of 253 residues, with the first 65 residues being unique, and the remaining 188 COOHterminal residues (starting at EEQVAQ that marks the beginning of exon 3) being identical to that of the canonical form. Exons are represented by boxes (with filled boxes corresponding to protein coding fragments) and introns by lines, respectively.
anti-BAK AB simply cross reacted with a yet undefined protein (CRP in Fig. 3 ) that is not part of the pulled down NKA-Bcl-2 protein complexes.
Immunocolocalization in FHLCs. Colocalization of BclXL and NKA-␣1 subunits in FHLCs was demonstrated with rb anti-hBclXL ABs from Abcam and ms monoclonal anti-NKA ABs from Millipore. Figure 8A shows a green FITCstaining of a group of FHL124 cells by the secondary antibody to anti-BclXL, Fig. 8B the corresponding red CY3-staining by the secondary antibody to anti-NKA, Fig.  8C the merger between A and B, and Fig. 8D the merger including the nuclear stain DAPI. In both mergers, the arrow points to orange-yellow membrane staining where the overlap between BcLXL and NKA is clearly visible along the periphery of one cell suggesting colocalization of the two proteins. Figure 9 is a confocal image with the same antibody combinations as in Fig. 8 . Indicated by arrows, there is distinct orange staining in the perinuclear endoplasmic reticulum zone, suggesting early assembly in the biosynthesis of the two proteins, as well as orange staining of membrane folding heralding arrival of the binary complex at the plasma membrane.
To detect BAK1 and NKA ␣1-overlap in FLECs, Millipore anti-NKA AB and ms monoclonal anti-NKA ␣1-subunit AB were used. The epifluorescence picture in Fig. 10A shows punctate FITC-staining of BAK, Fig. 10B intense CY3 red staining of membrane NKA, both nicely overlapping in Fig.  10 , C and D (DAPI), with prevalence of punctated cytosolic and membrane colocalization of both BAK and NKA.
The anti-BAK AB of Fig. 10 was the same polyclonal antibody that revealed a 37-kDa peptide in the IP experiments of Fig. 3 . Since a subsequent gel (Fig. 4) with a monoclonal anti-BAK1 AB failed to show this protein band, we concluded that the Santa Cruz antibody cross reacted with the unidentified protein (BAK-CRP). To rule out the possibility of a false positive immunocolocalization, the monoclonal anti-BAK from Abcam and the Millipore anti-NKA antibodies were tested in the immunocolocalization experiment shown in Fig. 11 . Again, as in Fig. 10 , there were distinct orange-and yellow-colored punctates but also membrane overlaps between the two AB signals clearly indicating colocalization of NKA and BAK1.
In summary, our immunocytochemistry results clearly established that both prosurvival BcLXL and proapoptotic BAK1 colocalize with the NKA in FHLECs, complementing our coimmunoprecipitation data and, together, support our in silico-derived proposal that the NKA possesses binding motifs for these two Bcl-2 proteins (21). Experiments analyzing the peptide sequence of the proposed splice variant of BAK1 as well as confirming by FRET the proximity and exact cellular localization of NKA and Bcl-2 proteins are in progress.
Conclusion.
The novel findings shown here further support the role of NKA, perhaps as a ternary molecular complex sensor, assembled in the ER, in the survival and apoptotic processes of living cells as hypothesized (21) . Figure 12 offers two putative models of NKA ternary complex formation with BclXL and BAK1 variant (BAK1v). In Fig 12A, the NKA NH 2 terminus scaffolds BclXL via BH1/BH3 (indented circles/ triangles) or BH3/BH1 (triangles/indented circles) interactions. BclXL itself (but not NKA) might scaffold the extended variant BAK1v by similar interactions and thus complete a minimum ternary complex. This model would require that NKA and BclXL are coimmunoprecipitated reciprocally, and that BAK1v was pulled down by NKA, but not vice versa. However, our results (Fig. 6) showed that neither BAK1v nor BclXL reciprocally pulled down NKA as do BH3-BH1-groove-interacting Bcl-2 molecules. This increases the likelihood that NKA scaffolds both BclXL and BAK1v through its BH1 and BH3 motif interactions as proposed in model B. Motif occlusion, the fivefold differences in molecular masses between NKA and Bcl-2 peptides, or other yet unknown factors may explain why this presumed scaffolding process escapes reciprocal detection.
It remains to be seen whether the in silico sites found by us (21) are actually the sites to which the Bcl-2 BclXL and BAK proteins bind vis a vis their BH3 motifs or BH1-adjacent grooves. Other Bcl-2 proteins and BH3-only peptides need be tested. As shown first by the group of Xie (40), the cationdependent conformations of NKA are coupled to and hence modulate its interaction with Src, one of the two partners of a putative transport-signalosome. Therefore, we anticipate that the interaction with the Bcl-2 proteins may be under the control of a similar paradigm, and studies to this effect are planned in the future. The exciting aspect of our discovery is that, in the end, the ratio of prosurvival and proapoptotic proteins may determine NKA function. Conversely, the latter may respond actively to the Bcl-2 protein ratio, thus determining quiescent growth or shutdown of NKA such as in normal lens fiber cells (9) or in the well known low potassium erythrocytes polymorphism in ungulates and carnivores (20) . Promotion of fulminant chemotherapy-resistant cancer growth, suppressed by long-term exposure to hypoxia (42) , may be another example of the Bcl-2 protein ratio control. It is well known that the Bcl-2 protein ratio is affected by erythropoietin, which upregulates BcLXL and does not affect BAK (26) . Since erythropoietin levels are a function of the partial pressure of oxygen, it is not unreasonable to postulate here that cellular ionic equilibria are a direct function of the physical environment of living systems, especially of the partial gas pressure of oxygen, perhaps a key to explain this singular curiosity in the animal kingdom.
